Growth Equity

Growth equity is a private equity strategy that takes minority stakes in established, profitable or near-profitable companies seeking capital to accelerate expansion — new markets, product lines, or acquisitions. Growth equity sits between venture capital (early-stage, loss-making companies) and leveraged buyouts (mature companies acquired with debt) in the private markets spectrum.

Allocator Relevance: Growth equity is the fastest-growing private equity sub-strategy by AUM. It offers higher return potential than buyouts (higher growth companies) with lower leverage risk than LBOs, appealing to LPs seeking a middle-path between VC volatility and PE stability.

Market Position

Private equity funds — which include growth equity alongside buyout strategies — totaled 25,155 registered funds with $8.0 trillion in NAV as of Q3 2025 (SEC Form PF, aggregated by Altss). Growth equity as a distinct category has expanded rapidly since 2015, with managers including General Atlantic, Insight Partners, and Vista Equity Partners raising multi-billion-dollar vehicles dedicated to the strategy.

Origins

Growth equity emerged as a distinct strategy in the 1980s and 1990s as venture-backed technology companies reached profitability but sought institutional capital before going public. General Atlantic's investments in ADP, First Data, and Priceline in this era defined the modern growth equity playbook: minority stake, board seat, no leverage, value-added beyond capital.

How Growth Equity Works

The fund acquires a minority stake (20–40%) in a company generating $5M–$100M in revenue with a demonstrated business model. Unlike LBOs, growth equity transactions use minimal or no debt — returns come entirely from revenue and EBITDA growth plus market multiple expansion. The GP takes a board seat and actively assists with strategic planning, hiring, and follow-on M&A. Exits occur via IPO, strategic acquisition, or sponsor-to-sponsor secondary.

Key Distinguishing Features

• No leverage — returns depend entirely on business growth, not financial engineering
• Minority ownership — GP does not control the company; founder typically retains majority stake and operational control
• Profitable or near-profitable companies — unlike VC, which invests pre-revenue; unlike PE, which targets mature cash-flow businesses
• Shorter hold periods — 3–5 years versus 5–7 for LBOs, driven by faster underlying growth

Risk and Return

Target net IRRs range from 20–30%, higher than buyout on average due to higher company growth rates and lower leverage risk. Primary risks are revenue growth miss (the company grows slower than projected) and multiple compression (market re-rates growth companies lower at exit). Since there is no debt buffer, equity is fully exposed to business underperformance.

Common Misconceptions

• Growth equity is not late-stage venture — growth equity companies have proven business models and established revenue; VC invests in uncertain early-stage bets
• Minority ownership does not mean passive — growth equity GPs are active board members with contractual rights over major decisions
• Growth equity is not low-risk — growth multiple compression (as seen in 2022) can produce negative returns despite revenue growth

Key Takeaways

• Growth equity targets minority stakes in proven, high-growth businesses — lower leverage risk than buyout, lower binary risk than venture
• Returns (20–30% target net IRR) come entirely from revenue growth and market re-rating; financial engineering plays no role
• LP due diligence must examine revenue quality (recurring vs. transactional), TAM expansion potential, and management team depth